Lurosetron
![]() | |
Systematic (IUPAC) name | |
---|---|
6-fluoro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one | |
Clinical data | |
Identifiers | |
128486-54-4 ![]() 143486-90-2 (mesylate) | |
None | |
PubChem | CID 172999 |
ChemSpider |
151068 ![]() |
UNII |
G694G740ZP ![]() |
KEGG |
D04821 ![]() |
Chemical data | |
Formula | C17H17FN4O |
312.341 g/mol | |
SMILES
| |
| |
![]() |
Lurosetron (INN) is a serotonin 5-HT3 receptor antagonist.[1]
References
- ↑ Prakash SP, Cable KM, Correa ID, Fellows L, Montgomery S, Newman JJ, Waterhouse L, Wells GN, Sutherland DR. Synthesis of isotopically labelled pyridoindolone 5-HT3 receptor antagonists. Journal of Labelled Compounds and Radiopharmaceuticals. 1995; 36(10):993-1007.